I made a similar generalization about dentists a number of years back. I regret making that generalization now.
I wish I had instead decided “that one can’t be trusted, let me try another”.
I also went through that with dentists years back and had several in a row insisting I needed lots of expensive work but I kept spending on more opinions as it was out of line with my historical dental health. I lucked into one that confirmed I did not need any of that, proved why to my satisfaction, and said its a real problem in the business and I have been with them ever since.
One big advantage of immunotherapy is that the therapy causes a long-term (permanent? I'm not sure anyone knows; the drugs are less than a decade old) change to the immune system - the body continues to attack the cancer even after the drug treatment has ceased.
If you put these two things together, however, you might see why the side effects can be so bizarre. Your immune system might decide that the liver looked at it funny one day, but then decide that the GI tract is actually the real troublemaker a few days later. And since the immune system change persists post-treatment, so do the side effects.
These side effects can (usually) be controlled with corticosteroids (hydrocortisone/prednisone/etc.), which have an immunosuppressant effect. Of course, long-term corticosteroid use has its own severe side effects (plus severe dependency issues). And if you're suppressing the immune system, then you're suppressing the mechanism that the immunotherapy uses to fight the cancer in the first place. The treatment and the side effects are two sides of the same coin.
That sounds like checkpoint inhibitor immunotherapy. Others like CAR-T may have fewer side effects, since they're just augmenting your T cells with a manufactured supply that is primed to attack a specific target.
CAR-T is a lot more expensive for now but over time such "precision" immunotherapies may become mass produced and cheaper and we'll be able to make the immune system do what we want with fewer side effects.
You are correct. That is because the article is about checkpoint inhibitor immunotherapy (specifically yervoy/ipilimumab and opdivo/nivolumab).
Our immune systems are fantastically complicated, probably more complex a defense system than the entire US military with hundreds of millions of years of evolutionary pressure.